Smith & Nephew (SN) Competitors

Smith & Nephew logo
GBX 1,025.50 -1.00 (-0.10%)
As of 02/14/2025

SN vs. SGE, WHR, ANP, CLX, TPX, PNPL, LEG, ULVR, HLN, and MXCT

Should you be buying Smith & Nephew stock or one of its competitors? The main competitors of Smith & Nephew include The Sage Group (SGE), Warehouse REIT (WHR), Anpario (ANP), Calnex Solutions (CLX), TPXimpact (TPX), Pineapple Power (PNPL), Legendary Investments (LEG), Unilever (ULVR), Haleon (HLN), and MaxCyte (MXCT).

Smith & Nephew vs.

Smith & Nephew (LON:SN) and The Sage Group (LON:SGE) are both large-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, media sentiment, dividends, community ranking, profitability and analyst recommendations.

Smith & Nephew has a beta of 0.62, suggesting that its stock price is 38% less volatile than the S&P 500. Comparatively, The Sage Group has a beta of 0.53, suggesting that its stock price is 47% less volatile than the S&P 500.

Smith & Nephew presently has a consensus target price of GBX 4,607.50, indicating a potential upside of 349.29%. The Sage Group has a consensus target price of GBX 3,446.67, indicating a potential upside of 161.11%. Given Smith & Nephew's stronger consensus rating and higher probable upside, analysts plainly believe Smith & Nephew is more favorable than The Sage Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Smith & Nephew
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00
The Sage Group
2 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.14

Smith & Nephew has higher revenue and earnings than The Sage Group. Smith & Nephew is trading at a lower price-to-earnings ratio than The Sage Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Smith & Nephew£7.08B1.59£382.79M£27.7736.92
The Sage Group£2.14B6.09£254.60M£25.7351.31

In the previous week, Smith & Nephew and Smith & Nephew both had 1 articles in the media. Smith & Nephew's average media sentiment score of 0.00 equaled The Sage Group'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Smith & Nephew
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
The Sage Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Smith & Nephew pays an annual dividend of GBX 29 per share and has a dividend yield of 2.8%. The Sage Group pays an annual dividend of GBX 20 per share and has a dividend yield of 1.5%. Smith & Nephew pays out 104.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. The Sage Group pays out 77.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

62.2% of Smith & Nephew shares are held by institutional investors. Comparatively, 67.0% of The Sage Group shares are held by institutional investors. 0.2% of Smith & Nephew shares are held by insiders. Comparatively, 1.1% of The Sage Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Smith & Nephew received 34 more outperform votes than The Sage Group when rated by MarketBeat users. Likewise, 62.02% of users gave Smith & Nephew an outperform vote while only 44.96% of users gave The Sage Group an outperform vote.

CompanyUnderperformOutperform
Smith & NephewOutperform Votes
560
62.02%
Underperform Votes
343
37.98%
The Sage GroupOutperform Votes
526
44.96%
Underperform Votes
644
55.04%

The Sage Group has a net margin of 11.87% compared to Smith & Nephew's net margin of 5.41%. The Sage Group's return on equity of 24.48% beat Smith & Nephew's return on equity.

Company Net Margins Return on Equity Return on Assets
Smith & Nephew5.41% 5.85% 4.51%
The Sage Group 11.87%24.48%7.58%

Summary

Smith & Nephew beats The Sage Group on 10 of the 18 factors compared between the two stocks.

Get Smith & Nephew News Delivered to You Automatically

Sign up to receive the latest news and ratings for SN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SN vs. The Competition

MetricSmith & NephewMedical Devices IndustryMedical SectorLON Exchange
Market Cap£11.24B£3.35B£5.75B£2.64B
Dividend Yield3.66%2.42%5.27%5.03%
P/E Ratio36.9265.8025.88155.96
Price / Sales1.59151.04468.11324,015.02
Price / Cash18.6815.3846.0627.86
Price / Book1.724.337.305.28
Net Income£382.79M£116.55M£3.19B£5.68B
7 Day Performance2.40%-1.04%1.69%2.91%
1 Month PerformanceN/A-0.02%4.13%3.43%
1 Year Performance-8.19%22.86%22.24%150.40%

Smith & Nephew Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SN
Smith & Nephew
3.7181 of 5 stars
GBX 1,025.50
-0.1%
GBX 4,607.50
+349.3%
-7.5%£11.24B£7.08B36.9218,452News Coverage
High Trading Volume
SGE
The Sage Group
2.3904 of 5 stars
GBX 1,321.50
0.0%
GBX 3,446.67
+160.8%
+11.6%£13.17B£2.25B5,082.6911,326Dividend Increase
WHR
Warehouse REIT
4.1538 of 5 stars
GBX 80.30
+1.0%
GBX 108
+34.5%
+1.1%£341.16M£51.03M1,003.7561,000
ANP
Anpario
0.8653 of 5 stars
GBX 442.50
+2.9%
GBX 435
-1.7%
+86.1%£74.83M£32.72M2,458.33109Gap Up
CLX
Calnex Solutions
1.8263 of 5 stars
GBX 65.31
-2.5%
GBX 115
+76.1%
-25.4%£57.19M£16.27M1,756.339,000
TPX
TPXimpact
N/AGBX 27.20
-2.9%
N/A-26.7%£24.84M£84.27M-113.3312,000Gap Down
PNPL
Pineapple Power
N/AN/AN/AN/A£2.28MN/A-274.002High Trading Volume
LEG
Legendary Investments
N/AN/AN/AN/A£0.00N/A0.0019,900Gap Down
ULVR
Unilever
1.0671 of 5 stars
GBX 4,728.45
+0.6%
GBX 4,665
-1.3%
+9.2%£117.27B£60.29B2,149.30148,000
HLN
Haleon
0.8227 of 5 stars
GBX 387.20
+2.1%
GBX 415
+7.2%
+19.0%£35.00B£11.26B3,226.6725,408
MXCT
MaxCyte
N/AGBX 358
+1.4%
N/A-12.5%£376.22M£45.44M-1,376.9280

Related Companies and Tools


This page (LON:SN) was last updated on 2/17/2025 by MarketBeat.com Staff
From Our Partners